Updated Phase 2 Trial Data Looks Promising for Experimental Alpha-1 Antitrypsin Deficiency Therapy
According to an a press release published on Business Wire, Arrowhead Pharmaceuticals Inc. recently presented updated phase 2 data at the 2023 European Association for the Study of the Liver…